SGLT2 Inhibitors as a Therapeutic Option for Diabetic Nephropathy

International Journal of Molecular Sciences
Daiji KawanamiKazunori Utsunomiya

Abstract

Diabetic nephropathy (DN) is a major cause of end-stage renal disease (ESRD) worldwide. Glycemic and blood pressure (BP) control are important but not sufficient to attenuate the incidence and progression of DN. Sodium-glucose cotransporter (SGLT) 2 inhibitors are a new class of glucose-lowering agent suggested to exert renoprotective effects in glucose lowering-dependent and independent fashions. Experimental studies have shown that SGLT2 inhibitors attenuate DN in animal models of both type 1 diabetes (T1D) and type 2 diabetes (T2D), indicating a potential renoprotective effect beyond glucose reduction. Renoprotection by SGLT2 inhibitors has been demonstrated in T2D patients with a high cardiovascular risk in randomized controlled trials (RCTs). These favorable effects of SGLT2 inhibitors are explained by several potential mechanisms, including the attenuation of glomerular hyperfiltration, inflammation and oxidative stress. In this review article, we discuss the renoprotective effects of SGLT2 inhibitors by integrating experimental findings with the available clinical data.

References

Mar 1, 1988·Diabetes/metabolism Reviews·S Anderson, B M Brenner
Sep 5, 2002·Annual Review of Physiology·Jürgen Schnermann, David Z Levine
Dec 6, 2003·American Journal of Physiology. Renal Physiology·Scott C ThomsonRoland C Blantz
Feb 1, 1951·The Journal of Clinical Investigation·S J FARBERD P EARLE
May 5, 2006·Journal of the American Society of Nephrology : JASN·Etienne B SochettJudith A Miller
May 6, 2008·TheScientificWorldJournal·Audrey Koitka, Christos Tikellis
Sep 5, 2008·Experimental Diabetes Research·Slava MalatialiMario Barac-Nieto
Jul 10, 2010·Journal of the American Society of Nephrology : JASN·Volker VallonTimo Rieg
Apr 30, 2011·Physiological Reviews·Ernest M WrightBruce A Hirayama
May 25, 2011·Endocrine Reviews·Muhammad A Abdul-GhaniRalph A Defronzo
Oct 18, 2011·Seminars in Nephrology·Diana I JalalTakahiko Nakagawa
Feb 18, 2012·Annual Review of Physiology·Volker Vallon, Scott C Thomson
Mar 15, 2012·Experimental Cell Research·Tetsuhiro Tanaka, Masaomi Nangaku
Nov 15, 2012·American Journal of Physiology. Endocrinology and Metabolism·David R PowellBrian Zambrowicz
Dec 12, 2012·Oxidative Medicine and Cellular Longevity·Horacio OsorioBruno Escalante
Mar 16, 2013·The Journal of Pharmacology and Experimental Therapeutics·Naoki KojimaRichard J Roman
May 15, 2013·Diabetes, Obesity & Metabolism·H J Lambers HeerspinkJ List
Aug 1, 2013·BMJ : British Medical Journal·Atsushi GotoMitsuhiko Noda
Mar 8, 2014·Journal of the American Society of Hypertension : JASH·William L BakerWilliam B White
Mar 29, 2014·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Luca De NicolaRoberto Minutolo
Apr 3, 2014·Journal of Internal Medicine·M A Abdul-Ghani, R A DeFronzo
Oct 12, 2014·Pflügers Archiv : European journal of physiology·Ivana VrhovacHermann Koepsell
Nov 8, 2014·American Journal of Physiology. Renal Physiology·Yuliya LytvynDavid Z I Cherney
Jan 23, 2015·Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Métabolisme·A OjimaS Yamagishi
Mar 19, 2015·TheScientificWorldJournal·L ZanoliP Castellino
May 23, 2015·Diabetes, Obesity & Metabolism·C D SjöströmE Johnsson

❮ Previous
Next ❯

Citations

Dec 13, 2018·American Journal of Physiology. Renal Physiology·Markus PirklbauerHerbert Schramek
Jan 23, 2019·Diabetes·Radica Z AlicicKatherine R Tuttle
Nov 14, 2019·American Journal of Physiology. Cell Physiology·Danúbia Silva Dos SantosAdriana C C Girardi
Jul 17, 2020·Journal of Diabetes·Aman RajpalFaramarz Ismail-Beigi
Jun 7, 2018·The Journal of Biological Chemistry·Diogo de Barros PeruchettiCelso Caruso-Neves
Aug 5, 2018·Journal of Cellular Physiology·Habib YaribeygiAmirhossein Sahebkar
Jul 13, 2019·International Journal of Molecular Sciences·Keiichiro MatobaRimei Nishimura
Oct 25, 2017·Nature Reviews. Nephrology·Kengo AzushimaThomas M Coffman
Aug 20, 2019·Expert Review of Molecular Diagnostics·Petra ZürbigHarald Mischak
Jun 18, 2020·International Journal of Molecular Sciences·Daiji KawanamiMakito Tanabe
Sep 11, 2020·Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [and] German Diabetes Association·Stella PapachristouNikolaos Papanas
Jul 3, 2018·Diabetes & Vascular Disease Research : Official Journal of the International Society of Diabetes and Vascular Disease·Natalia de Albuquerque RochaDarren K McGuire
Nov 18, 2018·Journal of Cellular Physiology·Habib YaribeygiAmirhossein Sahebkar
May 25, 2018·Current Medicinal Chemistry·Panagiotis I GeorgianosVassilios Liakopoulos
Feb 27, 2020·Biomedicines·Keiichiro MatobaRimei Nishimura
Apr 1, 2020·Archives of Physiology and Biochemistry·Nisha SharmaAnil Bhanudas Gaikwad
Jan 29, 2021·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Shengfeng WanFengmin Shao
Nov 3, 2020·SN Comprehensive Clinical Medicine·Antonio Vitiello, Francesco Ferrara
Nov 4, 2020·International Journal of Molecular Sciences·Markus PirklbauerHerbert Schramek
Feb 11, 2021·Antioxidants·Daiji KawanamiMakito Tanabe
Nov 24, 2020·Cardiovascular Diabetology·Francesco GiorginoAnna Solini
Nov 29, 2020·The Journal of Clinical Endocrinology and Metabolism·Ashley S ChaEmily Beth Devine
Jul 6, 2020·Diabetes Research and Clinical Practice·In-Kyung JeongMoon Kyu Lee
Apr 17, 2021·International Journal of Endocrinology·Gerui LiJinping Lu
May 20, 2021·Antioxidants & Redox Signaling·Thomas EbertPaul G Shiels
Jun 3, 2021·International Journal of Molecular Sciences·Markus PirklbauerHerbert Schramek
Jun 1, 2021·International Journal of Cardiology·Francesco MarantaDomenico Cianflone

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsy

Clinical Trials Mentioned

NCT02065791
NCT01032629
NCT01989754

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.